CollPlant Biotechnologies
CLGN
CLGN
17 hedge funds and large institutions have $12.5M invested in CollPlant Biotechnologies in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 18 → 17 (-1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.95M | |
| 2 | +$23.9K | |
| 3 | +$12K | |
| 4 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$414 |
Top Sellers
| 1 | -$135K | |
| 2 | -$92.7K | |
| 3 | -$70.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.9K |
| 5 |
Morgan Stanley
New York
|
-$408 |